Rock Springs Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.17M Sell
68,600
-90,700
-57% -$1.55M 0.07% 83
2025
Q1
$10.2M Sell
159,300
-148,200
-48% -$9.46M 0.58% 50
2024
Q4
$37.4M Hold
307,500
1.42% 25
2024
Q3
$38.4M Buy
307,500
+23,500
+8% +$2.93M 1.25% 31
2024
Q2
$44.9M Sell
284,000
-43,600
-13% -$6.89M 1.35% 30
2024
Q1
$42.4M Hold
327,600
1.08% 35
2023
Q4
$31.6M Sell
327,600
-64,400
-16% -$6.21M 0.78% 43
2023
Q3
$47.5M Sell
392,000
-33,000
-8% -$4M 1.27% 28
2023
Q2
$48.7M Sell
425,000
-17,500
-4% -$2M 1.16% 29
2023
Q1
$61M Buy
442,500
+6,500
+1% +$896K 1.46% 25
2022
Q4
$56.5M Buy
436,000
+6,000
+1% +$777K 1.36% 26
2022
Q3
$47.5M Buy
430,000
+2,000
+0.5% +$221K 1.23% 25
2022
Q2
$32.1M Hold
428,000
0.93% 39
2022
Q1
$33.4M Buy
428,000
+4,000
+0.9% +$312K 0.84% 40
2021
Q4
$38.2M Buy
424,000
+74,000
+21% +$6.66M 0.88% 38
2021
Q3
$32.4M Buy
350,000
+21,250
+6% +$1.97M 0.68% 49
2021
Q2
$25.6M Hold
328,750
0.51% 63
2021
Q1
$24.5M Hold
328,750
0.53% 64
2020
Q4
$56M Sell
328,750
-16,750
-5% -$2.86M 1.19% 26
2020
Q3
$48.5M Hold
345,500
1.23% 28
2020
Q2
$55.4M Hold
345,500
1.52% 14
2020
Q1
$33.8M Hold
345,500
1.4% 24
2019
Q4
$44.6M Buy
345,500
+8,000
+2% +$1.03M 1.41% 15
2019
Q3
$25.4M Buy
337,500
+12,500
+4% +$942K 1.01% 32
2019
Q2
$49.4M Sell
325,000
-9,500
-3% -$1.44M 1.79% 11
2019
Q1
$39.9M Buy
334,500
+7,500
+2% +$894K 1.54% 12
2018
Q4
$35.7M Buy
327,000
+16,500
+5% +$1.8M 1.68% 12
2018
Q3
$50.1M Buy
310,500
+13,000
+4% +$2.1M 1.82% 12
2018
Q2
$39.3M Buy
297,500
+39,500
+15% +$5.22M 1.51% 15
2018
Q1
$19.1M Hold
258,000
0.82% 42
2017
Q4
$14.4M Sell
258,000
-1,200
-0.5% -$66.8K 0.65% 57
2017
Q3
$11.8M Buy
259,200
+54,200
+26% +$2.46M 0.54% 61
2017
Q2
$6.91M Buy
205,000
+11,000
+6% +$371K 0.35% 83
2017
Q1
$5.74M Buy
194,000
+2,100
+1% +$62.2K 0.33% 85
2016
Q4
$5.26M Buy
191,900
+18,900
+11% +$518K 0.35% 76
2016
Q3
$10.6M Buy
173,000
+42,000
+32% +$2.58M 0.67% 51
2016
Q2
$2.5M Hold
131,000
0.18% 109
2016
Q1
$2.56M Buy
131,000
+23,500
+22% +$459K 0.21% 105
2015
Q4
$4.15M Buy
+107,500
New +$4.15M 0.31% 95